BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8276954)

  • 1. Pulsatile gonadotrophin releasing hormone versus gonadotrophin treatment of hypothalamic hypogonadism in males.
    Schopohl J
    Hum Reprod; 1993 Nov; 8 Suppl 2():175-9. PubMed ID: 8276954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of gonadotropin-releasing hormone and gonadotropin therapy in male patients with idiopathic hypothalamic hypogonadism.
    Schopohl J; Mehltretter G; von Zumbusch R; Eversmann T; von Werder K
    Fertil Steril; 1991 Dec; 56(6):1143-50. PubMed ID: 1743335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of testicular growth and spermatogenesis by pulsatile, intravenous administration of gonadotrophin-releasing hormone in patients with hypogonadotrophic hypogonadism.
    Delemarre-Van de Waal HA
    Clin Endocrinol (Oxf); 1993 May; 38(5):473-80. PubMed ID: 8330443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotrophic hypogonadism.
    Kirk JM; Savage MO; Grant DB; Bouloux PM; Besser GM
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):57-63. PubMed ID: 7914153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases.
    Büchter D; Behre HM; Kliesch S; Nieschlag E
    Eur J Endocrinol; 1998 Sep; 139(3):298-303. PubMed ID: 9758439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulsatile GnRH treatment in boys and girls with idiopathic hypogonadotrophic hypogonadism.
    Delemarre-Van de Waal HA; Odink RJ
    Hum Reprod; 1993 Nov; 8 Suppl 2():180-3. PubMed ID: 8276956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF; Liu ZX; Nie M; Wang X; Xu HL; Huang BK; Zheng JJ; Min L; Kaiser UB; Wu XY
    Asian J Androl; 2017; 19(6):680-685. PubMed ID: 28051040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulsatile gonadotropin releasing hormone therapy for spermatogenesis in congenital hypogonadotropic hypogonadism patients who had poor response to combined gonadotropin therapy.
    Huang Z; Wang X; Yu B; Ma W; Zhang P; Wu X; Nie M; Mao J
    Arch Endocrinol Metab; 2024 May; 68():e230101. PubMed ID: 38739523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gordon Holmes spinocerebellar ataxia: a gonadotrophin deficiency syndrome resistant to treatment with pulsatile gonadotrophin-releasing hormone.
    Quinton R; Barnett P; Coskeran P; Bouloux PM
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):525-9. PubMed ID: 10583322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spermatogenesis of pulsatile gonadotropin-releasing hormone infusion versus gonadotropin therapy in male idiopathic hypogonadotropic hypogonadism].
    Huang B; Mao J; Xu H; Wang X; Liu Z; Nie M; Wu X
    Zhonghua Yi Xue Za Zhi; 2015 May; 95(20):1568-71. PubMed ID: 26463603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism.
    Lin J; Mao J; Wang X; Ma W; Hao M; Wu X
    Medicine (Baltimore); 2019 Aug; 98(31):e16616. PubMed ID: 31374027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital combined pituitary hormone deficiency patients have better responses to gonadotrophin-induced spermatogenesis than idiopathic hypogonadotropic hypogonadism patients.
    Mao J; Xu H; Wang X; Huang B; Liu Z; Zhen J; Nie M; Min L; Wu X
    Hum Reprod; 2015 Sep; 30(9):2031-7. PubMed ID: 26141714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of puberty in a patient with hypogonadotropic hypogonadism: effect of sequentially applied hCG and pulsatile GnRH administration.
    Klingmüller D; Menger D; Wildt L; Leyendecker G; Krück F; Schweikert HU
    Horm Metab Res; 1985 Jul; 17(7):358-61. PubMed ID: 3928472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism.
    Burgués S; Calderón MD
    Hum Reprod; 1997 May; 12(5):980-6. PubMed ID: 9194651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pulsatile subcutaneous gonadotropin-releasing hormone and exogenous gonadotropins in the treatment of men with isolated hypogonadotropic hypogonadism.
    Liu L; Chaudhari N; Corle D; Sherins RJ
    Fertil Steril; 1988 Feb; 49(2):302-8. PubMed ID: 3123278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of spermatogenesis with gonadotrophins in Chinese men with hypogonadotrophic hypogonadism.
    Kung AW; Zhong YY; Lam KS; Wang C
    Int J Androl; 1994 Oct; 17(5):241-7. PubMed ID: 7698849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-administered subcutaneous human menopausal gonadotrophin for the stimulation of testicular growth and the initiation of spermatogenesis in hypogonadotrophic hypogonadism.
    Jones TH; Darne JF
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):203-8. PubMed ID: 8435901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of spermatogenesis in isolated hypogonadotrophic hypogonadism with gonadotrophins and early intervention with intracytoplasmic sperm injection.
    Yong EL; Lee KO; Ng SC; Ratnam SS
    Hum Reprod; 1997 Jun; 12(6):1230-2. PubMed ID: 9222007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J; De Vits A; Joostens M; Van Royen E
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.